Home / Research / Product codes / OWD Medical-device intelligence
OWD: Somatic Gene Mutation Detection System FDA product code OWD: Somatic Gene Mutation Detection System. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code OWD
FDA device name Somatic Gene Mutation Detection System
Device class 3
Regulation number Not provided
Medical specialty Unknown
Review panel PA FDA definition The somatic gene mutation detection system is an in vitro diagnostic nucleic acid amplification and real-time detection system for the identification of genetic mutations in DNA extracted from human tumor tissues. Explore unknown records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 0 clearance records and 13 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Jul 31, 2012 to Aug 22, 2023.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 13 matching records Device / record Company in FDA record Source Source date therascreen KRAS RGQ PCR Kit (24)-IVD qualitative PCR assay used on the Rotor-Gene Q MDx instrument for the detection of seven somatic mutations … Z-2665-2023 · OWDQiagen GmbH Recall Sep 29, 2023FDA classification date therascreen FGFR RGQ RT-PCR kit (US IVD)
REF 874721 Z-1650-2022 · OWDQiagen Sciences LLC Recall Aug 29, 2022FDA record creation date therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US)
REF 874711 Z-1651-2022 · OWDQiagen Sciences LLC Recall Aug 29, 2022FDA record creation date FGFR RGQ RT-PCR Kit (RUO, not IVD)
REF 8747010 Z-1652-2022 · OWDQiagen Sciences LLC Recall Aug 29, 2022FDA record creation date therascreen KRAS RGQ PCR Kit (24)
Model Number(s): REF 870021 (US IVD) Z-0951-2022 · OWDQiagen Sciences LLC Recall Apr 19, 2022FDA record creation date therascreen KRAS RGQ PCR Kit (24)
REF 874052 (Japan IVD, not released in the USA) Z-0952-2022 · OWDQiagen Sciences LLC Recall Apr 19, 2022FDA record creation date cobas EGFR Mutation Test v2-Somatic gene mutation detection system
Catalog Number :07248563190 Z-0083-2022 · OWDRoche Molecular Systems, Inc. Recall Oct 8, 2021FDA record creation date therascreen PIK3CA RGQ PCR Kit (23) US IVD product- aid clinicians in identifying breast cancer patients who may be eligible for treatment with P… Z-0937-2021 · OWDQiagen Sciences LLC Recall Jan 29, 2021FDA record creation date cobas EGFR Mutation Test V2
Materials number
CE-IVD: EGFR v2: 07248563190
cfDNA: 07247737190
Device Identifier:
EGFR v2.0: 00875197005448
cfDNA… Z-2254-2016 · OWDRoche Molecular Systems, Inc. Recall Jul 21, 2016FDA record creation date cobas EGFR Mutation Test, v2 and cobas cfDNA Sample
Preparation Hungarian Translation Instructions for Use Z-1830-2016 · OWDRoche Molecular Systems, Inc. Recall May 26, 2016FDA record creation date cobas 4800 KRAS AMP/DET 24T CE-IVD Mutation Test; CE-IVD 5852170190.
Intended for the identification of mutations in codons 12,13 and 61 of the … Z-0999-2015 · OWDRoche Molecular Systems, Inc. Recall Jun 26, 2015FDA classification date cobas EGFR Mutation Test
epidermal growth factor receptor (EGFR) gene DNA assay Z-1320-2015 · OWDRoche Molecular Systems, Inc. Recall Mar 25, 2015FDA classification date cobas 4800 BRAF V600 Mutation Test for In Vitro Diagnostic Use Roche Molecular Systems, Inc.,
Product Usage:
The primary use of the cobas 48… Z-0188-2013 · OWDRoche Molecular Systems, Inc. Recall Nov 2, 2012FDA classification date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗